Clinical Trial Update: Vaginal Microbiome Exposure and Immune Responses in C-section Infants [EARLY_Phase 1]

View source ↗

Summary

This is an EARLY_PHASE1 clinical trial update about how exposure to the vaginal microbiome at birth may influence immune responses in C-section infants, sponsor…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Diseases
• Asthma

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Allergic Diseases, Asthma | EARLY_Phase 1 | Status: ACTIVE_NOT_RECRUITING